BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
Novel treatments for neurological disorders reported in recent patent literature
May 23, 2008
New phase III data reported for Q-8003IR dual opioid therapy
May 23, 2008
NPL-2005 awarded U.S. orphan drug status for fragile X syndrome
May 23, 2008
Lundbeck acquires European commercialization rights to Flurizan
May 23, 2008
Newron completes patient enrollment in phase III safinamide study
May 23, 2008
FDA accepts Anesiva's supplemental NDA filing to expand indication for Zingo
May 22, 2008
Myogane receives orphan medicinal product designation from EMEA
May 22, 2008
Recent Wyeth and Takeda patents disclose novel antipsychotic and antidepressant agents
May 21, 2008
BioAlliance acquires European rights to ondansetron oral spray
May 21, 2008
KAI Pharmaceuticals initiates enrollment in phase I clinical study of KAI-1678
May 21, 2008
Previous
1
2
…
1744
1745
1746
1747
1748
1749
1750
1751
1752
…
3010
3011
Next
RSS